Table 7.

Multivariate analyses of predicting hematoma expansion in the propensity score-matched cohorts.

	Adjusteda OR	95% CI	P-value
>6 mL growth
WBC count	0.93	0.87–0.98	0.021
Neutrophil count	0.91	0.86–0.97	0.006
Monocyte count	1.48	0.75–2.93	0.252
Lymphocyte count	1.17	0.92–1.48	0.192
Eosinophil count	9.36	1.46–59.68	0.018
>12.5 mL growth
WBC count	0.98	0.91–1.06	0.599
Neutrophil count	0.95	0.88–1.03	0.224
Monocyte count	1.43	1.04–1.97	0.024
Lymphocyte count	1.34	0.98–1.84	0.061
Eosinophil count	14.50	1.17–178.88	0.037
>33% growth
WBC count	0.93	0.87–0.99	0.032
Neutrophil count	0.91	0.85–0.97	0.007
Monocyte count	1.91	0.82–4.42	0.131
Lymphocyte count	1.17	0.92–1.48	0.191
Eosinophil count	11.04	1.47–82.66	0.019
>6 mL or 33% growth
WBC count	0.94	0.89–0.99	0.04
Neutrophil count	0.92	0.87–0.98	0.009
Monocyte count	1.87	0.89–3.91	0.096
Lymphocyte count	1.20	0.97–1.50	0.09
Eosinophil count	6.92	1.20–39.78	0.03
>12.5 mL or 33% growth
WBC count	0.96	0.90–1.02	0.22
Neutrophil count	0.93	0.87–1.00	0.058
Monocyte count	2.03	0.87–4.71	0.1
Lymphocyte count	1.20	0.94–1.52	0.138
Eosinophil count	31.60	3.23–308.70	0.003

OR for 10³ cells increase.

^aAdjusted for history of cerebral hemorrhage, glasgow coma scale score, time to initial computed tomography, and baseline hematoma volume. WBC, white blood cell; OR, odds ratio; CI, confidence interval.